Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1995 Oct;71(840):613–616. doi: 10.1136/pgmj.71.840.613

The effect of nilvadipine on bloodflow in the dorsal pedis artery in type 2 diabetic patients--a study using duplex Doppler ultrasonography.

H Sone 1, Y Okuda 1, M Mizutani 1, Y Kawakami 1, C Bannai 1, K Yamashita 1
PMCID: PMC2398257  PMID: 8545290

Abstract

The effects of nilvadipine on the peripheral circulation in the lower extremities using a duplex system of two-dimensional colour and pulse Doppler ultrasonography were studied in 32 patients with type 2 diabetes mellitus and mild essential hypertension. The patients (19 men and 13 women) were randomly divided into treatment and control groups. The anatomical cross-sectional area and blood flow index of the dorsal pedis artery were determined by colour and pulse Doppler ultrasonography before and 60 min after administration of 4 mg nilvadipine or placebo. Pulse rate and blood pressure were measured simultaneously. There were no significant changes in pulse rate or blood pressure after administration of either drug. Both cross-sectional areas (from 4.3 +/- 0.4 to 5.2 +/- 0.5 mm2, p < 0.05) and blood flow index (from 40.3 +/- 4.3 to 58.8 +/- 9.0, p < 0.05) were significantly increased in the treatment group, whereas there were no significant changes in either measurement in the control group. The findings showed that a single administration of nilvadipine increases blood flow in the dorsal pedis arteries of diabetic patients.

Full text

PDF
613

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coffman J. D. Intermittent claudication--be conservative. N Engl J Med. 1991 Aug 22;325(8):577–578. doi: 10.1056/NEJM199108223250810. [DOI] [PubMed] [Google Scholar]
  2. Furuichi Y., Takakura S., Satoh H., Mori J., Kohsaka M. The effect of nilvadipine, a dihydropyridine type calcium channel blocker, on local cerebral blood flow in rats. Jpn J Pharmacol. 1992 Apr;58(4):457–460. doi: 10.1254/jjp.58.457. [DOI] [PubMed] [Google Scholar]
  3. Greene D. A., Lattimer S. A., Sima A. A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med. 1987 Mar 5;316(10):599–606. doi: 10.1056/NEJM198703053161007. [DOI] [PubMed] [Google Scholar]
  4. Johnson P. C., Doll S. C., Cromey D. W. Pathogenesis of diabetic neuropathy. Ann Neurol. 1986 May;19(5):450–457. doi: 10.1002/ana.410190505. [DOI] [PubMed] [Google Scholar]
  5. Nilsson G. E., Tenland T., Obert P. A. A new instrument for continuous measurement of tissue blood flow by light beating spectroscopy. IEEE Trans Biomed Eng. 1980 Jan;27(1):12–19. doi: 10.1109/TBME.1980.326686. [DOI] [PubMed] [Google Scholar]
  6. Ohtsuka M., Ono T., Hiroi J., Esumi K., Kikuchi H., Kumada S. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists. J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):1074–1082. doi: 10.1097/00005344-198311000-00024. [DOI] [PubMed] [Google Scholar]
  7. Terakawa M., Tokuma Y., Shishido A., Noguchi H. Pharmacokinetics of nilvadipine in healthy volunteers. J Clin Pharmacol. 1987 Feb;27(2):111–117. doi: 10.1002/j.1552-4604.1987.tb02170.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES